Skip to content

13F-HR filed by Camber Capital Management LP

Camber Capital Management LP filed this 13F-HR for the quarter ended 2016-03-31, filed 2016-05-13, with 48 holding rows worth $1,707,656,000.

Accession
0001354488-16-007412
Filed
2016-05-13
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2016

A holdings report, 48 entries on the cover page, a total value of $1,707,656,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,707,657,000 with VALUE read as thousands by filing date, 13F file number 028-13745. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR2,250,000$120,398,000thousands by filing date
MYLAN NVN59465109SHS EURO1,850,000$85,748,000thousands by filing date
MEDICINES CO584688105COM2,500,000$79,425,000thousands by filing date
BROOKDALE SR LIVING INC112463104COM5,000,000$79,400,000thousands by filing date
NUVASIVE INC670704105COM1,500,000$72,975,000thousands by filing date
ST JUDE MED INC790849103COM1,250,000$68,750,000thousands by filing date
SELECT MED HLDGS CORP81619Q105COM5,575,000$65,841,000thousands by filing date
LIVANOVA PLCG5509L101SHS1,200,000$64,776,000thousands by filing date
ORTHOFIX INTL N VN6748L102COM1,500,000$62,280,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM4,500,000$61,875,000thousands by filing date
GENOMIC HEALTH, INC.37244C101COM2,458,100$60,887,000thousands by filing date
LDR HLDG CORP50185U105COM2,250,000$57,353,000thousands by filing date
TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS881624209ADR1,000,000$53,510,000thousands by filing datecall
VALEANT PHARMACEUTICALS INTL91911K102COM2,000,000$52,600,000thousands by filing date
AbbVie,Inc.00287Y109COM900,000$51,408,000thousands by filing date
Gilead Sciences,Inc.375558103COM500,000$45,930,000thousands by filing datecall
BIOGEN INC COM09062X103Stock175,000$45,556,000thousands by filing date
TENET HEALTHCARE CORP88033G100COMMON STOCK1,500,000$43,395,000thousands by filing date
QUEST DIAGNOSTICS INC COM74834L100Stock600,000$42,870,000thousands by filing date
CARDIOVASCULAR SYSTEMS INC020390010COM4,100,000$42,517,000thousands by filing date
UNIVERSAL AMERN CORP NEW91338E101COM5,875,000$41,948,000thousands by filing date
MASIMO CORP COM574795100Stock1,000,000$41,840,000thousands by filing date
ALKERMES INC01642T108COMMON STOCK1,200,000$41,028,000thousands by filing date
MEDIVATION INC58501N101COM825,000$37,934,000thousands by filing date
ARIAD PHARMACEUTICALS INC04033A100COM5,405,235$34,539,000thousands by filing date
ENDOLOGIX INC29266S106COM3,864,500$32,307,000thousands by filing date
INVITAE CORP46185L103COM2,746,622$28,098,000thousands by filing date
SEQUENOM INC COM NEW817337405COM17,325,000$24,428,000thousands by filing date
WRIGHT MED GROUP N VN96617118ORD SHS1,452,600$24,113,000thousands by filing date
ARENA PHARMACEUTICALS INC004004710COM10,500,000$20,685,000thousands by filing date
ORASURE TECHNOLOGIES INC68554V108COM2,000,000$14,460,000thousands by filing date
AMAG PHARMACEUTICALS INC00163U106COM600,000$14,040,000thousands by filing date
BIOSCRIP INC09069N108COM6,180,000$13,225,000thousands by filing date
PROTALIX BIOTHERAPEUTICS INC74365A101COM13,275,000$11,158,000thousands by filing date
SYNERON MEDICAL LTDM87245102ORD1,505,700$11,007,000thousands by filing date
INNOCOLL AG47580Q103COM1,111,111$9,533,000thousands by filing date
DURECT CORP266605104COM6,000,000$8,100,000thousands by filing date
BIOLASE INC090911108COMMON STOCK5,332,394$6,985,000thousands by filing date
PROTALIX BIOTHERAPEUTICS INC74365AAB7NOTE 4.500% 9/19,000,000$6,000,000thousands by filing dateprincipal
PTC THERAPEUTICS INC69366J200COM893,900$5,757,000thousands by filing date
CATABASIS PHARMACEUTICALS IN14875P107COM1,000,000$5,040,000thousands by filing date
EPIRUS Biopharmaceuticals Inc29428P107Common Stock1,847,500$4,970,000thousands by filing date
GENMARK DIAGNOSTICS INC372309104COM649,097$3,421,000thousands by filing date
ANGIODYNAMICS INC03475V101COM243,183$2,989,000thousands by filing date
CARDICA INC14141R309COM NEW837,483$2,981,000thousands by filing date
UNILIFE CORP NEW90478E103COM2,750,000$1,870,000thousands by filing date
TARGACEPT INC87611RAA6NOTE 2/11,684,799$1,685,000thousands by filing dateprincipal
BIOLASE INC909911108WARRANTS1,841,173$22,000thousands by filing datecall

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001354488-16-007412this filing2016-05-13acceptance time not in the bulk data set